Amniotic membrane mesenchymal stem cells labeled by iron oxide nanoparticles exert cardioprotective effects against isoproterenol (ISO)-induced myocardial damage by targeting inflammatory MAPK/NF-κB pathway

[1]  M. Nikougoftar,et al.  Comparison of the effects of intramyocardial and intravenous injections of human mesenchymal stem cells on cardiac regeneration after heart failure , 2020, Iranian journal of basic medical sciences.

[2]  M. Nikougoftar,et al.  Conditioned medium obtained from human amniotic mesenchymal stem cells attenuates focal cerebral ischemia/reperfusion injury in rats by targeting mTOR pathway , 2019, Journal of Chemical Neuroanatomy.

[3]  T. Webster,et al.  Would Colloidal Gold Nanocarriers Present An Effective Diagnosis Or Treatment For Ischemic Stroke? , 2019, International journal of nanomedicine.

[4]  A. Akbarzadeh,et al.  Tailoring synthetic polymeric biomaterials towards nerve tissue engineering: a review , 2019, Artificial cells, nanomedicine, and biotechnology.

[5]  J. Key,et al.  Strategies to enhance efficacy of SPION-labeled stem cell homing by magnetic attraction: a systemic review with meta-analysis , 2019, International journal of nanomedicine.

[6]  A. Shafiee,et al.  Controlling Cell Behavior through the Design of Biomaterial Surfaces: A Focus on Surface Modification Techniques , 2019, Advanced Materials Interfaces.

[7]  A. Mashaghi,et al.  Selenium nanoparticles for targeted stroke therapy through modulation of inflammatory and metabolic signaling , 2019, Scientific Reports.

[8]  Hao Zhang,et al.  Iron oxide nanoparticles promote the migration of mesenchymal stem cells to injury sites , 2019, International journal of nanomedicine.

[9]  S. Rossi,et al.  In Situ Gelling Scaffolds Loaded with Platelet Growth Factors to Improve Cardiomyocyte Survival after Ischemia. , 2018, ACS biomaterials science & engineering.

[10]  T. Webster,et al.  Three-Dimensional Graphene Foams: Synthesis, Properties, Biocompatibility, Biodegradability, and Applications in Tissue Engineering. , 2018, ACS biomaterials science & engineering.

[11]  N. Naderi,et al.  ELABELA (ELA) Peptide Exerts Cardioprotection Against Myocardial Infarction by Targeting Oxidative Stress and the Improvement of Heart Function , 2019, International Journal of Peptide Research and Therapeutics.

[12]  A. Sahu,et al.  Role of MAPK/NF-κB pathway in cardioprotective effect of Morin in isoproterenol induced myocardial injury in rats , 2019, Molecular Biology Reports.

[13]  K. Parivar,et al.  The effects of superparamagnetic iron oxide nanoparticles-labeled mesenchymal stem cells in the presence of a magnetic field on attenuation of injury after heart failure , 2018, Drug Delivery and Translational Research.

[14]  N. Naderi,et al.  Targeting necroptotic cell death pathway by high-intensity interval training (HIIT) decreases development of post-ischemic adverse remodelling after myocardial ischemia / reperfusion injury , 2018, Journal of Cell Communication and Signaling.

[15]  K. Rakhshan,et al.  Natural lavender oil (Lavandula angustifolia) exerts cardioprotective effects against myocardial infarction by targeting inflammation and oxidative stress , 2018, Inflammopharmacology.

[16]  R. David,et al.  Stem Cell Therapy in Heart Diseases – Cell Types, Mechanisms and Improvement Strategies , 2018, Cellular Physiology and Biochemistry.

[17]  Hala F Zaki,et al.  Paradoxical effects of atorvastatin in isoproterenol-induced cardiotoxicity in rats: Role of oxidative stress and inflammation. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[18]  L. Fields,et al.  Fibrin Glue-aided, Instant Epicardial Placement Enhances the Efficacy of Mesenchymal Stromal Cell-Based Therapy for Heart Failure , 2018, Scientific Reports.

[19]  Hyung-Seok Kim,et al.  Gallic acid improves cardiac dysfunction and fibrosis in pressure overload-induced heart failure , 2018, Scientific Reports.

[20]  B. S. Ramalho,et al.  Injection of bone marrow mesenchymal stem cells by intravenous or intraperitoneal routes is a viable alternative to spinal cord injury treatment in mice , 2018, Neural regeneration research.

[21]  Andrew J Taylor,et al.  Mechanisms responsible for increased circulating levels of galectin-3 in cardiomyopathy and heart failure , 2018, Scientific Reports.

[22]  Furong Guo,et al.  Pin1 facilitates isoproterenol-induced cardiac fibrosis and collagen deposition by promoting oxidative stress and activating the MEK1/2-ERK1/2 signal transduction pathway in rats , 2017, International journal of molecular medicine.

[23]  G. Vunjak‐Novakovic,et al.  Paracrine Effects of Mesenchymal Stromal Cells Cultured in Three-Dimensional Settings on Tissue Repair. , 2017, ACS biomaterials science & engineering.

[24]  G. Golomb,et al.  Monocyte-mediated drug delivery systems for the treatment of cardiovascular diseases , 2018, Drug Delivery and Translational Research.

[25]  O. Akhavan,et al.  Antioxidant nanomaterials in advanced diagnoses and treatments of ischemia reperfusion injuries. , 2017, Journal of materials chemistry. B.

[26]  A. Zaher,et al.  The Effect of Different Routes of Injection of Bone Marrow Mesenchymal Stem Cells on Parotid Glands of Rats Receiving Cisplatin: A Comparative Study , 2017, International journal of stem cells.

[27]  Yong Wang,et al.  The long-term fate of mesenchymal stem cells labeled with magnetic resonance imaging-visible polymersomes in cerebral ischemia , 2017, International journal of nanomedicine.

[28]  R. Malhotra,et al.  Febuxostat Modulates MAPK/NF-κBp65/TNF-α Signaling in Cardiac Ischemia-Reperfusion Injury , 2017, Oxidative medicine and cellular longevity.

[29]  J. Traverse.  Is There a Role for Intravenous Stem Cell Delivery in Nonischemic Cardiomyopathy? , 2017, Circulation research.

[30]  M. Jeong,et al.  Gallic acid prevents isoproterenol-induced cardiac hypertrophy and fibrosis through regulation of JNK2 signaling and Smad3 binding activity , 2016, Scientific Reports.

[31]  K. Parivar,et al.  Magnetic Resonance Imaging of Human-Derived Amniotic Membrane Stem Cells Using PEGylated Superparamagnetic Iron Oxide Nanoparticles , 2016, Cell journal.

[32]  J. Simard,et al.  Cell-Based Therapy in TBI: Magnetic Retention of Neural Stem Cells in Vivo , 2016, Cell transplantation.

[33]  Jinlin Song,et al.  Strategies to Optimize Adult Stem Cell Therapy for Tissue Regeneration , 2016, International journal of molecular sciences.

[34]  R. Malhotra,et al.  Mangiferin protect myocardial insults through modulation of MAPK/TGF-β pathways. , 2016, European journal of pharmacology.

[35]  Phillip C. Yang,et al.  Magnetic Nanoparticles for Targeting and Imaging of Stem Cells in Myocardial Infarction , 2016, Stem cells international.

[36]  I. Altuntaş,et al.  Molecular and biochemical evidence on the protective effects of embelin and carnosic acid in isoproterenol-induced acute myocardial injury in rats. , 2016, Life sciences.

[37]  Alexander M Seifalian,et al.  Stem cell tracking using iron oxide nanoparticles , 2014, International journal of nanomedicine.

[38]  Weimin Li,et al.  In vivo MRI tracking of iron oxide nanoparticle-labeled human mesenchymal stem cells in limb ischemia , 2013, International journal of nanomedicine.

[39]  Eva Syková,et al.  Highly efficient magnetic targeting of mesenchymal stem cells in spinal cord injury , 2012, International journal of nanomedicine.

[40]  U. Häfeli,et al.  Focused Magnetic Stem Cell Targeting to the Retina Using Superparamagnetic Iron Oxide Nanoparticles , 2012, Cell transplantation.

[41]  A. Hagège,et al.  Can Magnetic Targeting of Magnetically Labeled Circulating Cells Optimize Intramyocardial Cell Retention? , 2012, Cell transplantation.

[42]  M. Zarrindast,et al.  Expression of Bcl-2 and Bax after hippocampal ischemia in DHA + EPA treated rats , 2011, Neurological Sciences.

[43]  A. Firooz,et al.  Combination of azelaic acid 5% and erythromycin 2% in the treatment of acne vulgaris , 2010, The Journal of dermatological treatment.

[44]  M. Mehra,et al.  Chronic heart failure: contemporary diagnosis and management. , 2010, Mayo Clinic proceedings.

[45]  Anthony J. Muslin,et al.  MAPK signalling in cardiovascular health and disease: molecular mechanisms and therapeutic targets. , 2008, Clinical science.